Generic Drug Safety

Generics make up 90 percent of the American drug supply, notes Katherine Eban, author of the forthcoming Bottle of Lies: The Inside Story of the Generic Drug Boom. Eban argues, however, that foreign inspections reveal dangerous compromises behind the production of generic drugs—and FDA’s limits as a global regulatory agency.

Want to learn more?

DIA 2019Our upcoming DIA 2019 Global Annual Meeting features numerous sessions and perspectives on generic drugs, or take our online course on Postmarketing Safety Management.